Stay updated on Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial page.

Latest updates to the Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial page
- Check2 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, signaling a new release of the page template or tooling; there are no visible content changes to the study details.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page’s revision tag changed from v3.6.2 to v3.6.3. This reflects a deployment/version update rather than a change to the page content.SummaryDifference0.1%

- Check30 days agoChange DetectedThe page now shows revision v3.6.2, replacing the previous v3.6.0. This indicates a newer revision of the page content and related materials.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page now includes new guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the recruitment status to No longer looking for participants, indicating no current enrollment. A header formatting change and a revision label update are also present.SummaryDifference0.5%

- Check52 days agoChange Detected- The page revision was updated from v3.5.4 to v3.5.5, signaling a minor page-level update. No study content, eligibility criteria, or results information appear to have changed.SummaryDifference0.1%

- Check73 days agoChange Detected- The page revision label was updated to v3.5.4, replacing the previous v3.5.3 and signaling a minor update to the page without changing its study details.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial page.